Correlation Between Valneva SE and Connect Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Connect Biopharma Holdings, you can compare the effects of market volatilities on Valneva SE and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Connect Biopharma.

Diversification Opportunities for Valneva SE and Connect Biopharma

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Valneva and Connect is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of Valneva SE i.e., Valneva SE and Connect Biopharma go up and down completely randomly.

Pair Corralation between Valneva SE and Connect Biopharma

Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Connect Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.62 times less risky than Connect Biopharma. The stock trades about -0.23 of its potential returns per unit of risk. The Connect Biopharma Holdings is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  104.00  in Connect Biopharma Holdings on September 13, 2024 and sell it today you would earn a total of  19.00  from holding Connect Biopharma Holdings or generate 18.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.45%
ValuesDaily Returns

Valneva SE ADR  vs.  Connect Biopharma Holdings

 Performance 
       Timeline  
Valneva SE ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Valneva SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Connect Biopharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Connect Biopharma Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Connect Biopharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Valneva SE and Connect Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Valneva SE and Connect Biopharma

The main advantage of trading using opposite Valneva SE and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.
The idea behind Valneva SE ADR and Connect Biopharma Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital